Post-market surveillanceAndrogen Modulator
Compound 61563
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061563
Risk Class
MODERATE
Last Audit
Apr 11, 2108
Research Abstract
Androgen Modulator candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Compound 61563 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for oncology adjuvant and inflammation control.
The dossier currently sits in post-market surveillance with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061563 with updates logged 2108-04-11.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Oncology adjuvantInflammation control
Nomenclature
CX-61563Androgen Modulator Program 61563
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061563
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61563